Exclusive agreement to bring state-of-the-art genome sequencing technology to the in vitro diagnostics market bioMerieux takes equity stake in Knome MARCY L’ETOILE, France and CAMBRIDGE, Mass. — bioMerieux and Knome announced today that they have entered into a strategic agreement to collaborate in the development of next-generation, sequence-based in vitro diagnostics. Under the agreement, bioMerieux […]
ITHACA, N.Y.–Rheonix, Inc. today announced the completion of a $12.6 million Series A financing to continue development of the Rheonix CARD™ (Chemistry And Reagent Device) system. This powerful, analytic platform for the life-science industry vertically integrates all the functions of traditional molecular diagnostic instrumentation into a single system to achieve unprecedented raw sample preparation, molecular […]
Roche Advances RG7348 into Clinical Development for Hepatitis C SAN DIEGO–Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) today announced that it earned a $6.5 million payment from Roche (SWX: ROG.VX; RO.S, OTCQX: RHHBY) as a result of Roche progressing RG7348 into a Phase I clinical trial for the treatment of hepatitis C viral (HCV) infection. The milestone […]
Lucigen Corporation is pleased to announce that it has recently been awarded three new grants to fund additional research and development. The National Institutes of Health has awarded Lucigen $1,764,732 in Small Business Innovation Research grants to be used over two years to develop research tools and diagnostic assays with potential to improve human health. […]
OXFORD, England and SAN DIEGO — Enigma Diagnostics Limited, the decentralised and point-of-care molecular diagnostics company, announced today that the U.S. Patent and Trademark Office has granted U.S. Patent No. 7,659,096 with claims that cover the use of amplification consumables in several current real-time and end point PCR instruments. The consumables incorporate a thermally conducting […]
MUKILTEO, Wash.– — CombiMatrix Corporation /quotes/comstock/15*!cbmx/quotes/nls/cbmx (CBMX 4.52, -0.15, -3.25%) announced today that it is implementing a restructuring plan to significantly reduce operating costs, increase the focus on the Company’s diagnostic services business and transition senior management. After the restructuring, CombiMatrix will be focused on its diagnostics services business, including increasing utilization of its existing […]
RUNCORN, Cheshire. — Thermo Fisher Scientific Inc., the world leader in serving science, today announced a new automated solution that labels and tracks patient tissue samples on cassettes and slides as they progress through pathology laboratories. The new solutions include the Thermo Scientific SlideMate on-demand slide printer and the Thermo Scientific PrintMate automated cassette printing […]
SALT LAKE CITY–Idaho Technology, Inc. has been awarded a contract by the U.S. Army Space and Missile Defense Command (USASMDC) to develop tests for multiple flu strains on the Joint Biological Agent Identification and Diagnostic System (JBAIDS). The JBAIDS instrument, already widely deployed across the globe, and the suite of flu tests that will result […]
Abbott’s PLEX- ID System Placed with the Utah Department of Health for Rapid and Broad Microorganism Identification SALT LAKE CITY — Abbott (NYSE: ABT) today announced that the Utah Department of Health (UDH) is one of five sites in the United States to participate in Abbott’s new PLEX-ID Biopreparedness Evaluation Program (BPEP), which involves Abbott, […]
Acquisition brings new diagnostic services to global leader in pre-natal and newborn health screening WALTHAM, Mass.–PerkinElmer, Inc. (NYSE: PKI), a global leader focused on the health and safety of people and the environment, today announced that it has entered into a definitive agreement to acquire Signature Genomic Laboratories, LLC (Signature), a diagnostic genetic testing company […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
